This is a randomized, triple-blind, controlled clinical trial evaluating the effects of Saje Pain Release Joint \& Arthritis Cream on symptoms of arthritis, joint pain, and muscle pain in adults aged 20-65. The trial is conducted virtually over seven days, with 80 participants randomized equally into an intervention arm (active topical cream) and a control arm (matched control product). Participants apply their assigned product three times daily to affected areas (knees, elbows, wrists, or ankles) and complete questionnaires at Baseline, 30 minutes after the first application, and at the end of Day 7. The primary objective is to assess changes in arthritis and musculoskeletal pain symptoms, while secondary objectives assess participants' perceptions of joint pain, stiffness, function, comfort, flexibility, mobility, and overall quality of life.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
80
40 participants apply a thin layer of the Saje Pain Release Joint \& Arthritis Cream to arthritis-affected areas (knees, elbows, wrists, ankles) three times daily (morning, afternoon, and evening) for seven days
40 participants apply a matched control product (identical in appearance and consistency to the active product but without active ingredients such as L-menthol and balsam copaiba oil) to arthritis-affected areas three times daily (morning, afternoon, and evening) for seven days
Citruslabs
Las Vegas, Nevada, United States
Change in symptoms of arthritis
Assessed via self-reported numerical pain rating scale and the Musculoskeletal Health Questionnaire (MSK-HQ) validated questionnaire
Time frame: Baseline, 30 minutes after first application, and Day 7
Change in symptoms of joint pain
Assessed via self-reported numerical pain rating scale and the Musculoskeletal Health Questionnaire (MSK-HQ) validated questionnaire
Time frame: Baseline, 30 minutes after first application, and Day 7
Change in symptoms of muscle pain
Assessed via self-reported numerical pain rating scale and the Musculoskeletal Health Questionnaire (MSK-HQ) validated questionnaire
Time frame: Baseline, 30 minutes after first application, and Day 7
Change in self-reported joint pain
Assessed via self-reported questionnaire
Time frame: Baseline, 30 minutes after first application, and Day 7
Change in self-reported joint stiffness
Assessed via self-reported questionnaire
Time frame: Baseline, 30 minutes after first application, and Day 7
Change in self-reported joint function
Assessed via self-reported questionnaire
Time frame: Baseline, 30 minutes after first application, and Day 7
Change in self-reported joint comfort
Assessed via self-reported questionnaire
Time frame: Baseline, 30 minutes after first application, and Day 7
Change in self-reported flexibility
Assessed via self-reported questionnaire
Time frame: Baseline, 30 minutes after first application, and Day 7
Change in self-reported mobility
Assessed via self-reported questionnaire
Time frame: Baseline, 30 minutes after first application, and Day 7
Change in self-reported quality of life
Assessed via self-reported questionnaire
Time frame: Baseline, 30 minutes after first application, and Day 7
Change in self-reported overall health
Assessed via self-reported questionnaire
Time frame: Baseline, 30 minutes after first application, and Day 7
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.